Table of Contents

Table of Contents

Preface
pp. vii-x

Chapter 1
Involvement of Brain-Derived Neurotrophic Factor (BDNF) in Huntington’s Disease
(Joana Gil-Mohapel, Division of Medical Sciences, UBC Island Medical Program, University of Victoria, Victoria, British Columbia, Canada)
pp. 1-42

Chapter 2
Experimental Rationale for Increasing Brain Derived Neurotrophic Factor (BDNF) in the Treatment of Diminished Glutamatergic Signaling in Schizophrenia
(Kenneth M. Johnson, Yan Xia, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA, and others)
pp. 43-66

Chapter 3
The Role of Brain-Derived Neurotrophic Factor (BDNF) in Cognition and Treatment Response
(Dubravka Svob Strac, Matea Nikolac Perkovic, Gordana Nedic Erjavec, Suzana Uzun, Marina Sagud, Maja Zivkovic, Oliver Kozumplik, Alma Mihaljevic-Peles, Aleksandra Sustar, and Nela Pivac, Rudjer Boskovic Institute, Division of Molecular Medicine, Zagreb, Croatia, and others)
pp. 67-146

Chapter 4
Abnormal Brain BDNF, “Leaky Gut” and Altered Microbiota in Autism
(Elizabeth M. Sajdel-Sulkowska, Michal Bialy, Agnieszka Cudnoch-Jedrzejewska, Dept. Experimental and Clinical Physiology, Warsaw Medical University, Warsaw, Poland, and others)
pp. 147-180

Chapter 5
ProBDNF Biology and Emerging Roles in the CNS: The Unexpected Journey of Proneurotrophins
(Margarita Arango-Lievano, Agustin Anastasia, Freddy Jeanneteau, Dep. Physiology, Institut de genomique fonctionelle; Inserm, Monpellier, France, and others)
pp. 181-198

Index
pp. 199-213